[1] Viaene AN,Lee EB,Rosenbaum JN,et al.Histologic,immunohistochemical,and molecular features of pituicytomas and atypical pituicytomas[J].Acta neuropathologica communications,2019,7(1):1~11.
[2] Brat DJ,Scheithauer BW,Staugaitis SM,et al.Pituicytoma:a distinctive low-grade glioma of the neurohypophysis[J].The American journal of surgical pathology,2000,24(3):362~368.
[3] Brat DJ,Scheithauer BW,Fuller GN,et al.Newly codified glial neoplasms of the 2007 WHO Classification of Tumours of the Central Nervous System:angiocentric glioma,pilomyxoid astrocytoma and pituicytoma[J].Brain pathology,2007,17(3):319~324.
[4] Iglesias P,Guerrero-Pérez F,Villabona C,et al.Adenohypophyseal hyperfunction syndromes and posterior pituitary tumors:prevalence,clinical characteristics,and pathophysiological mechanisms[J].Endocrine,2020,70(1):15~23.
[5] Liss L,Kahn EA.Pituicytoma.Tumor of the sella turcica:a clinicopathological study[J].Journal of Neurosurgery,1958,15(5):481~488.
[6] Louis D N,Perry A,Reifenberger G,et al.The 2016 World Health Organization classification of tumors of the central nervous system:a summary[J].Acta neuropathologica,2016,131(6):803~820.
[7] Brandão RACS,Braga MHV,de Souza AA,et al.Pituicytoma[J].Surgical Neurology International,2010,1(1):79.
[8] Schmalisch K,Schittenhelm J,Ebner F H,et al.Pituicytoma in a patient with Cushing's disease:case report and review of the literature[J].Pituitary,2012,15(1):10~16.
[9] Mete O,Lopes MB.Overview of the 2017 WHO classification of pituitary tumors[J].Endocrine Pathology,2017,28(3):228~243.
[10] Asa SL,Mete O,Perry A,et al.Overview of the 2022 WHO classification of pituitary tumors[J].Endocrine pathology,2022,33(1):6~26.
[11] Yoshimoto T,Takahashi-Fujigasaki J,Inoshita N,et al.TTF-1-positive oncocytic sellar tumor with follicle formation/ependymal differentiation:non-adenomatous tumor capable of two different interpretations as a pituicytoma or a spindle cell oncocytoma[J].Brain Tumor Pathology,2015,32(3):221~227.
[12] Takei H,Goodman JC,Tanaka S,et al.Pituicytoma incidentally found at autopsy[J].Pathology international,2005,55(11):745~749.
[13] Nakasu Y,Nakasu S,Saito A,et al.Pituicytoma-Two Case Reports-[J].Neurologia medico-chirurgica,2006,46(3):152~156.
[14] Chang TW,Lee CY,Jung S M,et al.Correlations between clinical hormone change and pathological features of pituicytoma[J].British Journal of Neurosurgery,2018,32(5):501~508.
[15] Shah B,Lipper MH,Laws ER,et al.Posterior pituitary astrocytoma:a rare tumor of the neurohypophysis:a case report[J].American journal of neuroradiology,2005,26(7):1858~1861.
[16] Al-Salihi MM,Ahmed A,Al-Jebur M S,et al.A rare case of pituicytoma-related hyperprolactinemia due to mass effect on infundibular stalk-Case report[J].International Journal of Surgery Case Reports,2023,107:108348.
[17] Gibbs WN,Monuki ES,Linskey ME,et al.Pituicytoma:diagnostic features on selective carotid angiography and MR imaging[J].American journal of neuroradiology,2006,27(8):1639~1642.
[18] Trifa A,Knafo S,Maatoug A,et al.Surgical management of pituicytomas:a single-center case series[J].Acta Neurologica Belgica,2023,123(3):815~822.
[19] Furtado S V,Ghosal N,Venkatesh P K,et al.Diagnostic and clinical implications of pituicytoma[J].Journal of Clinical Neuroscience,2010,17(7):938~943.
[20] Covington MF,Chin SS,Osborn A G.Pituicytoma,spindle cell oncocytoma,and granular cell tumor:clarification and meta-analysis of the world literature since 1893[J].American journal of neuroradiology,2011,32(11):2067~2072.
[21] Pascual JM,Prieto R,Carrasco R,et al.The 2013 Sixto Obrador Award.A triple-axis topographical model for surgical planning of craniopharyngiomas.Part II:anatomical and neuroradiological evidence to define triple-axis topography and its usefulness in predicting individual surgical risk[J].Neurocirugia (Asturias,Spain),2014,25(5):211~239.
[22] 杨虹,蒋冰,刘骞,等.18例垂体细胞瘤的临床病理特点分析[J].大连医科大学学报,2021,43(3):228~234.
[23] 司海鹏,王剑蓉,章宜芬,等.垂体细胞瘤及其罕见室管膜样亚型的临床病理分析[J].临床与实验病理学杂志,2018,34(3):284~288.
[24] Salge-Arrieta FJ,Carrasco-Moro R,Rodríguez-Berrocal V,et al.Clinical features,diagnosis and therapy of pituicytoma:an update[J].Journal of endocrinological investigation,2019,42:371~384.
[25] Chen B,Fan X,Zhang Z.Pituicytoma:report of three cases and a systematic literature review[J].Clinical Neurology and Neurosurgery,2021,205:106650.
[26] Kuga D,Toda M,Ozawa H,et al.Endoscopic endonasal approach combined with a simultaneous transcranial approach for giant pituitary tumors[J].World neurosurgery,2019,121:173~179.
[27] Gondim JA,Almeida JPC,Albuquerque LAF,et al.Giant pituitary adenomas:surgical outcomes of 50 cases operated on by the endonasal endoscopic approach[J].World neurosurgery,2014,82(1-2):e281~e290.
[28] Kuo CH,Yen YS,Wu JC,et al.Primary endoscopic transnasal transsphenoidal surgery for giant pituitary adenoma[J].World neurosurgery,2016,91:121~128.
[29] Wei LD,Li C,Li D,et al.Treatment and prognostic factors of pituicytoma:a single-center experience and comprehensive literature review[J].Pituitary,2021,24(5):754~767. |